Barriers and Enablers for Deprescribing Glucose-Lowering Treatment in Older Adults: A Systematic Review.

Objectives: Overtreatment with glucose-lowering treatment (GLT) is frequent and a source of high morbidity and mortality in older adults with type 2 diabetes mellitus (T2DM). This study aimed to identify and synthesize barriers and enablers for deprescribing GLT in older adults (≥65 years) with T2DM.

Design: Systematic review of qualitative and mixed-methods studies.